390 million treatments of Coartem® Dispersible delivered to over 50 countries
In 2009 Novartis and MMV launched the first high-quality artemisinin combination therapy (ACT) formulated especially for children – Coartem®Dispersible (artemether-lumefantrine). Since then, 390 million treatments of this life-saving medicine have been delivered to over 50 malaria-endemic countries.